Report
VOLUNTIS - BUY | Roche backs-off from its recent partnership extension with Voluntis
Roche backs-off from its recent partnership extension with VoluntisRoche terminates the extension part of the agreement
Doubts over breast cancer trial
We adjust our estimates and cautiously remove the Roche partnership
No impact on development of Voluntis' multi-cancer solution
Provider
Bryan Garnier
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Hugo Solvet
Other Reports from Bryan Garnier
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.